# Use of an Investigational Digital Therapeutic in Patients With Type 2 Diabetes

> **NCT05094401** · PHASE3 · TERMINATED · sponsor: **Better Therapeutics** · enrollment: 76 (actual)

## Conditions studied

- Type2 Diabetes

## Interventions

- **DEVICE:** BT-001

## Key facts

- **NCT ID:** NCT05094401
- **Lead sponsor:** Better Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-10-04
- **Primary completion:** 2023-04-01
- **Final completion:** 2023-04-01
- **Target enrollment:** 76 (ACTUAL)
- **Why stopped:** Sponsor/Investigator Decision
- **Last updated:** 2023-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05094401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05094401, "Use of an Investigational Digital Therapeutic in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05094401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*